|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-05S2
|
$37,430
|
$1,872
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-05
|
$1,396,397
|
$69,820
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
WESTERN ONCOLOGY RESEARCH CONSORTIUM
|
5U10CA045377-27
|
$589,569
|
$5,896
|
Conlin, Alison
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-29
|
$612,504
|
$6,125
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$52,897
|
$2,645
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
5R37CA050286-25
|
$430,440
|
$142,045
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Validation of Therapeutic Target Genes in Human Liver Cancer
|
ZIA BC 011175
|
$265,729
|
$39,859
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
|
5R01CA154823-03
|
$547,794
|
$547,794
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
7U01CA105492-10
|
$664,043
|
$166,011
|
HOLLAND, ERIC
|
FRED HUTCHINSON CAN RES CTR
|
|
Using Markers to Improve Pancreatic Cancer Screening
|
1R01CA176828-01A1
|
$416,716
|
$416,716
|
Goggins, Michael
|
JOHNS HOPKINS UNIVERSITY
|
|
Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life
|
5R21CA164449-02
|
$167,603
|
$33,521
|
Guadagnolo, Beverly
|
UT MD ANDERSON CANCER CTR
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-29
|
$1,065,000
|
$10,650
|
Bearden, James
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-27
|
$1,397,496
|
$307,449
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S1
|
$74,531
|
$4,472
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S2
|
$49,999
|
$3,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
$348,076
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
Ultrasound enhanced penetration for treatment of pancreatic cancer
|
5R01CA154451-03
|
$509,766
|
$509,766
|
HWANG, JOO
|
UNIVERSITY OF WASHINGTON
|
|
UCSD Cancer Nanotechnology Training Center
|
3R25CA153915-04S1
|
$44,940
|
$11,235
|
MATTREY, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
UCSD Cancer Nanotechnology Training Center
|
5R25CA153915-04
|
$350,118
|
$87,530
|
MATTREY, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
UAB / UMN SPORE in Pancreatic Cancer
|
5P50CA101955-09
|
$2,150,500
|
$2,150,500
|
BUCHSBAUM, DONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$336,277
|
$33,628
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
|
2P01CA067166-16A1
|
$1,600,018
|
$432,005
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
Tumor -Targeting Chemotherapeutic Agents
|
5R01CA103314-22
|
$295,691
|
$73,923
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Triptolide Augments Death Receptor Mediated Apoptosis in Pancreatic Cancer
|
5R01CA170946-02
|
$452,316
|
$452,316
|
SALUJA, ASHOK
|
UNIVERSITY OF MINNESOTA
|
|
Transmembrane Proteins Involved in Human Tumor Expansion
|
3R01CA105412-10S1
|
$30,332
|
$30,332
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
Transmembrane Proteins Involved in Human Tumor Expansion
|
5R01CA105412-10
|
$311,994
|
$311,994
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
Translational Research in GI Cancer
|
3P50CA130810-04S1
|
$163,133
|
$94,617
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN
|
|
Translational Research in GI Cancer
|
5P50CA130810-04
|
$2,051,220
|
$1,189,708
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN
|
|
Translational Research in Cancer
|
2P30CA056036-14
|
$2,647,679
|
$79,430
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-14S1
|
$73,216
|
$2,196
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transforming Growth Factor-Beta Signal Transduction
|
5R37CA034610-31
|
$435,215
|
$435,215
|
MASSAGUE, JOAN
|
SLOAN-KETTERING INST CAN RES
|
|
Transcriptional Coregulation in Pancreatic Adenocarcinoma Progression
|
1F30CA177123-01
|
$42,232
|
$42,232
|
Ferreira, Mark
|
UNIVERSITY OF PENNSYLVANIA
|
|
Training Program in Molecular Oncology and Immunology
|
5T32CA009161-38
|
$833,028
|
$166,606
|
Levy, David
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Toll-like Receptor Regulation of Pancreatic Tumorigenesis
|
1R01CA168611-01A1
|
$351,713
|
$351,713
|
Miller, George
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Tissue Factor splicing and pancreatic tumor progression: pilot studies
|
5R21CA160293-02
|
$192,592
|
$192,592
|
BOGDANOV, VLADIMIR
|
UNIVERSITY OF CINCINNATI
|
|
Therapeutic targeting of stratifin structure and function
|
5R01CA140582-04
|
$291,366
|
$291,366
|
ZHANG, JIAN-TING
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Therapeutic evaluation in GEM pancreatic model
|
ZIA BC 011526
|
$72,885
|
$72,885
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer
|
5U01CA151810-04
|
$471,193
|
$471,193
|
YANG, LILY
|
EMORY UNIVERSITY
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
5U10CA045809-25
|
$1,885,277
|
$169,675
|
FISCH, MICHAEL
|
UT MD ANDERSON CANCER CTR
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$742,894
|
$14,858
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Type III TGF-beta Receptor in the Fibrotic Tumor Stroma
|
1F31CA180602-01
|
$33,041
|
$16,521
|
Hesler, Rachel
|
DUKE UNIVERSITY
|
|
The role of the stromal cell surface protease FAP in pancreatic cancer
|
1R21CA169741-01A1
|
$224,460
|
$224,460
|
Pure', Ellen
|
WISTAR INSTITUTE
|
|
The role of telomere-related tetraploidization in cancer
|
5R01CA160924-03
|
$330,610
|
$165,305
|
de Lange, Titia
|
ROCKEFELLER UNIVERSITY
|
|
The Role of p120ctn in Pancreatic Ductal Morphogenesis and Adenocarcinoma
|
1F30CA180601-01
|
$45,637
|
$45,637
|
Bakir, Basil
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Role of glypican-1 in Pancreatic Cancer Development and Progression
|
5F32CA144579-03
|
$63,830
|
$63,830
|
Whipple, Chery
|
DARTMOUTH COLLEGE
|
|
The role of fibroblasts in the activities of tissue penetrating peptides
|
7R01CA167174-03
|
$233,318
|
$116,659
|
Sugahara, Kazuki
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of fibroblasts in the activities of tissue penetrating peptides
|
5R01CA167174-02
|
$114,131
|
$57,066
|
Sugahara, Kazuki
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-19
|
$4,635,678
|
$324,497
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-19S1
|
$75,000
|
$5,250
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-19S2
|
$50,000
|
$3,500
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Pancreas for this search: $101,936,107
|